Report Detail
Global Basal Cell Carcinoma Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
- RnM2766296 |
- 14 January, 2019 |
- Global |
- 116 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Basal cell carcinoma has a low metastasis rate and is more benign, so it is also called basal cell epithelial tumor. Based on its greater destructiveness, it is also called invasive ulcer. Basal cell carcinoma is more common in the elderly, and it occurs in the head, face, neck and back of the hand, especially the prominent part of the face. It begins with a small nodule that is skin-to-dark-infiltrated, typically waxy, translucent nodules with high curled edges. The central part begins to rupture, with black necrotic sputum, and the central necrosis spreads to the deep tissue, showing large invasive necrosis, which can reach soft tissue and bone tissue.
Scope of the Report:
This report focuses on the Basal Cell Carcinoma Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Among the many treatments, surgical resection is still the most effective treatment for the complete eradication of basal cell carcinoma and avoiding tumor recurrence.
In addition to surgical resection, other methods that can be used to treat basal cell carcinoma include: radiation therapy, photodynamic therapy, scraping electrocautery, cryotherapy, topical application of drugs, etc.
The worldwide market for Basal Cell Carcinoma Treatment is expected to grow at a CAGR of roughly 9.3% over the next five years, will reach 7700 million US$ in 2023, from 4520 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Sun Pharmaceuticals
Valeant Pharmaceuticals International
Mylan N.V.
F. Hoffmann-La Roche Ltd
Merck & Co.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Surgical Excision
Electrodessication & Cutterage
Moh's Surgery
Cryosurgery
Market Segment by Applications, can be divided into
Hospitals
Specialty Clinics
Others
There are 15 Chapters to deeply display the global Basal Cell Carcinoma Treatment market.
Chapter 1, to describe Basal Cell Carcinoma Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Basal Cell Carcinoma Treatment, with sales, revenue, and price of Basal Cell Carcinoma Treatment, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Basal Cell Carcinoma Treatment, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Basal Cell Carcinoma Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Basal Cell Carcinoma Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents
1 Market Overview
- 1.1 Basal Cell Carcinoma Treatment Introduction
- 1.2 Market Analysis by Type
- 1.2.1 Surgical Excision
- 1.2.2 Electrodessication & Cutterage
- 1.2.3 Moh's Surgery
- 1.2.4 Cryosurgery
- 1.3 Market Analysis by Applications
- 1.3.1 Hospitals
- 1.3.2 Specialty Clinics
- 1.3.3 Others
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2013-2023)
- 1.4.1.2 Canada Market States and Outlook (2013-2023)
- 1.4.1.3 Mexico Market States and Outlook (2013-2023)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2013-2023)
- 1.4.2.2 France Market States and Outlook (2013-2023)
- 1.4.2.3 UK Market States and Outlook (2013-2023)
- 1.4.2.4 Russia Market States and Outlook (2013-2023)
- 1.4.2.5 Italy Market States and Outlook (2013-2023)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2013-2023)
- 1.4.3.2 Japan Market States and Outlook (2013-2023)
- 1.4.3.3 Korea Market States and Outlook (2013-2023)
- 1.4.3.4 India Market States and Outlook (2013-2023)
- 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2013-2023)
- 1.4.4.2 Egypt Market States and Outlook (2013-2023)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
- 1.4.4.4 South Africa Market States and Outlook (2013-2023)
- 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 Sun Pharmaceuticals
- 2.1.1 Business Overview
- 2.1.2 Basal Cell Carcinoma Treatment Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Sun Pharmaceuticals Basal Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
- 2.2 Valeant Pharmaceuticals International
- 2.2.1 Business Overview
- 2.2.2 Basal Cell Carcinoma Treatment Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Valeant Pharmaceuticals International Basal Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
- 2.3 Mylan N.V.
- 2.3.1 Business Overview
- 2.3.2 Basal Cell Carcinoma Treatment Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Mylan N.V. Basal Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
- 2.4 F. Hoffmann-La Roche Ltd
- 2.4.1 Business Overview
- 2.4.2 Basal Cell Carcinoma Treatment Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 F. Hoffmann-La Roche Ltd Basal Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
- 2.5 Merck & Co.
- 2.5.1 Business Overview
- 2.5.2 Basal Cell Carcinoma Treatment Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 Merck & Co. Basal Cell Carcinoma Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Basal Cell Carcinoma Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
- 3.1 Global Basal Cell Carcinoma Treatment Sales and Market Share by Manufacturer (2016-2017)
- 3.2 Global Basal Cell Carcinoma Treatment Revenue and Market Share by Manufacturer (2016-2017)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Basal Cell Carcinoma Treatment Manufacturer Market Share in 2017
- 3.3.2 Top 6 Basal Cell Carcinoma Treatment Manufacturer Market Share in 2017
- 3.4 Market Competition Trend
4 Global Basal Cell Carcinoma Treatment Market Analysis by Regions
- 4.1 Global Basal Cell Carcinoma Treatment Sales, Revenue and Market Share by Regions
- 4.1.1 Global Basal Cell Carcinoma Treatment Sales and Market Share by Regions (2013-2018)
- 4.1.2 Global Basal Cell Carcinoma Treatment Revenue and Market Share by Regions (2013-2018)
- 4.2 North America Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 4.3 Europe Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 4.4 Asia-Pacific Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 4.5 South America Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 4.6 Middle East and Africa Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
5 North America Basal Cell Carcinoma Treatment by Countries
- 5.1 North America Basal Cell Carcinoma Treatment Sales, Revenue and Market Share by Countries
- 5.1.1 North America Basal Cell Carcinoma Treatment Sales and Market Share by Countries (2013-2018)
- 5.1.2 North America Basal Cell Carcinoma Treatment Revenue and Market Share by Countries (2013-2018)
- 5.2 United States Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 5.3 Canada Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 5.4 Mexico Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
6 Europe Basal Cell Carcinoma Treatment by Countries
- 6.1 Europe Basal Cell Carcinoma Treatment Sales, Revenue and Market Share by Countries
- 6.1.1 Europe Basal Cell Carcinoma Treatment Sales and Market Share by Countries (2013-2018)
- 6.1.2 Europe Basal Cell Carcinoma Treatment Revenue and Market Share by Countries (2013-2018)
- 6.2 Germany Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 6.3 UK Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 6.4 France Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 6.5 Russia Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 6.6 Italy Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
7 Asia-Pacific Basal Cell Carcinoma Treatment by Countries
- 7.1 Asia-Pacific Basal Cell Carcinoma Treatment Sales, Revenue and Market Share by Countries
- 7.1.1 Asia-Pacific Basal Cell Carcinoma Treatment Sales and Market Share by Countries (2013-2018)
- 7.1.2 Asia-Pacific Basal Cell Carcinoma Treatment Revenue and Market Share by Countries (2013-2018)
- 7.2 China Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 7.3 Japan Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 7.4 Korea Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 7.5 India Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 7.6 Southeast Asia Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
8 South America Basal Cell Carcinoma Treatment by Countries
- 8.1 South America Basal Cell Carcinoma Treatment Sales, Revenue and Market Share by Countries
- 8.1.1 South America Basal Cell Carcinoma Treatment Sales and Market Share by Countries (2013-2018)
- 8.1.2 South America Basal Cell Carcinoma Treatment Revenue and Market Share by Countries (2013-2018)
- 8.2 Brazil Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 8.3 Argentina Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 8.4 Colombia Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
9 Middle East and Africa Basal Cell Carcinoma Treatment by Countries
- 9.1 Middle East and Africa Basal Cell Carcinoma Treatment Sales, Revenue and Market Share by Countries
- 9.1.1 Middle East and Africa Basal Cell Carcinoma Treatment Sales and Market Share by Countries (2013-2018)
- 9.1.2 Middle East and Africa Basal Cell Carcinoma Treatment Revenue and Market Share by Countries (2013-2018)
- 9.2 Saudi Arabia Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 9.3 UAE Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 9.4 Egypt Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 9.5 Nigeria Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
- 9.6 South Africa Basal Cell Carcinoma Treatment Sales and Growth Rate (2013-2018)
10 Global Basal Cell Carcinoma Treatment Market Segment by Type
- 10.1 Global Basal Cell Carcinoma Treatment Sales, Revenue and Market Share by Type (2013-2018)
- 10.1.1 Global Basal Cell Carcinoma Treatment Sales and Market Share by Type (2013-2018)
- 10.1.2 Global Basal Cell Carcinoma Treatment Revenue and Market Share by Type (2013-2018)
- 10.2 Surgical Excision Sales Growth and Price
- 10.2.1 Global Surgical Excision Sales Growth (2013-2018)
- 10.2.2 Global Surgical Excision Price (2013-2018)
- 10.3 Electrodessication & Cutterage Sales Growth and Price
- 10.3.1 Global Electrodessication & Cutterage Sales Growth (2013-2018)
- 10.3.2 Global Electrodessication & Cutterage Price (2013-2018)
- 10.4 Moh's Surgery Sales Growth and Price
- 10.4.1 Global Moh's Surgery Sales Growth (2013-2018)
- 10.4.2 Global Moh's Surgery Price (2013-2018)
- 10.5 Cryosurgery Sales Growth and Price
- 10.5.1 Global Cryosurgery Sales Growth (2013-2018)
- 10.5.2 Global Cryosurgery Price (2013-2018)
11 Global Basal Cell Carcinoma Treatment Market Segment by Application
- 11.1 Global Basal Cell Carcinoma Treatment Sales Market Share by Application (2013-2018)
- 11.2 Hospitals Sales Growth (2013-2018)
- 11.3 Specialty Clinics Sales Growth (2013-2018)
- 11.4 Others Sales Growth (2013-2018)
12 Basal Cell Carcinoma Treatment Market Forecast (2018-2023)
- 12.1 Global Basal Cell Carcinoma Treatment Sales, Revenue and Growth Rate (2018-2023)
- 12.2 Basal Cell Carcinoma Treatment Market Forecast by Regions (2018-2023)
- 12.2.1 North America Basal Cell Carcinoma Treatment Market Forecast (2018-2023)
- 12.2.2 Europe Basal Cell Carcinoma Treatment Market Forecast (2018-2023)
- 12.2.3 Asia-Pacific Basal Cell Carcinoma Treatment Market Forecast (2018-2023)
- 12.2.4 South America Basal Cell Carcinoma Treatment Market Forecast (2018-2023)
- 12.2.5 Middle East and Africa Basal Cell Carcinoma Treatment Market Forecast (2018-2023)
- 12.3 Basal Cell Carcinoma Treatment Market Forecast by Type (2018-2023)
- 12.3.1 Global Basal Cell Carcinoma Treatment Sales Forecast by Type (2018-2023)
- 12.3.2 Global Basal Cell Carcinoma Treatment Market Share Forecast by Type (2018-2023)
- 12.4 Basal Cell Carcinoma Treatment Market Forecast by Application (2018-2023)
- 12.4.1 Global Basal Cell Carcinoma Treatment Sales Forecast by Application (2018-2023)
- 12.4.2 Global Basal Cell Carcinoma Treatment Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Summary:
Get latest Market Research Reports on Basal Cell Carcinoma Treatment . Industry analysis & Market Report on Basal Cell Carcinoma Treatment is a syndicated market report, published as Global Basal Cell Carcinoma Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Basal Cell Carcinoma Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
